Evidence map›Paper›PMID 31358843›Full record

ArticleScientific reports2019

Deletion of NFKB1 enhances canonical NF-κB signaling and increases macrophage and myofibroblast content during tendon healing.

Katherine T Best, Fredella K Lee, Emma Knapp, Hani A Awad, Alayna E Loiselle

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Mice lacking NF-ĸB1 undergo premature ovarian aging.Reproductive biology and endocrinology : RB&E · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Interfacial Tissue Regeneration with Bone.Current osteoporosis reports · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Katherine T BestCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, 14642, United States of America.
Fredella K LeeCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, 14642, United States of America.
Emma KnappCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, 14642, United States of America.
Hani A AwadCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, 14642, United States of America.
Alayna E LoiselleCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, 14642, United States of America. Alayna_Loiselle@urmc.rochester.edu.ORCID http://orcid.org/0000-0002-7548-6653
University of Rochester Medical Center · US

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Engineering scarless repair of flexor tendon injuriesR01AR056696 · NIAMS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, BENOIT, DANIELLE S. · 2009 to 2019
$3.6M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Defining the relationship between attenuated insulin receptor signaling and fibrosis in diabetic tendinopathyK01AR068386 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2016 to 2019
$484k
NIAMS NIH HHS K01 AR068386NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R01 AR056696NIAMS NIH HHS R01 AR073169U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) K01AR068386U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR056696U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR073169
6 · The paper itself

Abstract

Flexor tendon injuries heal with excessive scar tissue that limits range of motion and increases incidence of re-rupture. The molecular mechanisms that govern tendon healing are not well defined. Both the canonical nuclear factor kappa B (NF-κB) and mitogen activated protein kinase (MAPK) pathways have been implicated in tendon healing. The gene NFKB1 (proteins p105/p50) is involved in both NF-κB and MAPK signaling cascades. In the present study, we tested the hypothesis that global NFKB1 deletion would increase activation of both NF-κB and MAPK through loss of signaling repressors, resulting in increased matrix deposition and altered biomechanical properties. As hypothesized, NFKB1 deletion increased activation of both NF-κB and MAPK signaling. While gliding function was not affected, NFKB1 deletion resulted in tendons that were significantly stiffer and trending towards increased strength by four weeks post-repair. NFKB1 deletion resulted in increased collagen deposition, increase macrophage recruitment, and increased presence of myofibroblasts. Furthermore, NFKB1 deletion increased expression of matrix-related genes (Col1a1, Col3a1), macrophage-associated genes (Adgre1, Ccl2), myofibroblast markers (Acta2), and general inflammation (Tnf). Taken together, these data suggest that increased activation of NF-κB and MAPK via NFKB1 deletion enhance macrophage and myofibroblast content at the repair, driving increased collagen deposition and biomechanical properties.

Indexed as

Wound HealingActinsAnimalsCalcium-Binding ProteinsChemokine CCL2CollagenGene DeletionMacrophagesMiceMyofibroblastsNF-kappa B p50 SubunitReceptors, G-Protein-CoupledSignal TransductionTendon InjuriesTendonsTumor Necrosis Factor-alphaActa2 protein, mouseActinsAdgre1 protein, mouseCalcium-Binding ProteinsCcl2 protein, mouseChemokine CCL2CollagenNF-kappa B p50 SubunitNfkb1 protein, mouseReceptors, G-Protein-CoupledTumor Necrosis Factor-alpha

Identifiers

PMID31358843
PMCPMC6662789
OpenAlexW2966569083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.